Skip to content Skip to navigation

Jeff Settleman, "Reversible States of Drug Resistance in Cancer Cell Subpopulations"

December 3, 2018 - 4:00pm to 5:00pm
Clark Center Auditorium S001

Free and open to the public.

Jeff Settleman, Ph.D., is Distinguished Principal Investigator and Head of Oncology at Calico, a research and development company whose mission is to harness advanced technologies to increase our understanding of the biology that controls lifespan. His current research is largely focused on molecularly targeted cancer therapeutics, personalized cancer medicine, and epigenetic mechanisms of drug resistance. He is especially interested in developing a better understanding of the nature of dynamic fluctuation of phenotypic states within tumor cell subpopulations, and the role the consequent heterogeneity plays in tumor evolution, response to drug treatment, and other stressful exposures.

Event Sponsor: 
Department of Biology
Contact Email: 
ezavala@stanford.edu
Contact Phone: 
723-2413

Event Series: